← Back to headlines
Medicare's GLP-1 Bridge and Future of Biotech Discussed
An analysis explores Medicare's coverage of GLP-1 drugs and its potential implications for the future of the biotechnology sector.
1 Jul, 15:55 — 1 Jul, 15:55
Sources
Showing 1 of 1 sources
Related Stories
IMF Chief Warns Global Economy Faces Energy Shocks and Fiscal Pressures
11m ago
Abercrombie & Fitch Shares Surge on Strong Second-Quarter Earnings and Raised Guidance
26m ago
TWG Global Denies Fraud Allegations and Lakers Fire Sale Rumors Amid Federal Probe
30m ago
Analysts Downgrade Qifu Technology and Lower Intuit Price Targets on Sector Headwinds
33m ago